Equecabtagene Autoleucel Injection

DRUG2 trials

Sponsors

Nanjing IASO Biotechnology Co., Ltd., Tongji Hospital

Conditions

Lupus Nephritis (LN)Multiple MyelomaSystemic Lupus Erythematosus (SLE)

Phase 3

A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)

RecruitingNCT06464991

Nanjing IASO Biotechnology Co., Ltd.Multiple Myeloma

Start: 2024-03-27End: 2030-12-31Target: 240Updated: 2025-07-20

Unknown Phase

Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

RecruitingNCT06902844

Tongji HospitalLupus Nephritis (LN), Systemic Lupus Erythematosus (SLE)

Start: 2025-04-05End: 2028-01-10Target: 6Updated: 2025-03-30